Medical Device Industry News

MassDevice.com +3 | The top 3 medtech stories for February 27, 2015

February 27, 2015 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Joint FDA panel recommends OK for Avedro's eye treatment

February 27, 2015 by Mark Hollmer

A joint meeting of 2 FDA advisory panels backs the use of Avedro's cross-linking technology to treat 2 eye conditions.

Joint FDA panel recommends OK for Avedro's eye treatment

Avedro said a joint meeting of 2 FDA advisory panels
considering its corneal cross-linking technology to treat 2 eye conditions this week voted to recommend approval.

UnitedHealth tightens hysterectomy coverage

February 27, 2015 by MassDevice

UnitedHealth Group, the largest health insurer in the U.S., tightens its controls on hysterectomies performed using laparoscopic power morcellators.

UnitedHealth places tighter controls on hysterectomies

Fines remain rare even as health data breaches multiply

February 27, 2015 by MassDevice

Federal health watchdogs say they are cracking down on organizations that don’t protect the privacy and security of patient records, but data suggests otherwise.

Fines remain rare even as health data breaches multiply
(David Sleight/ProPublica)

by Charles Ornstein, ProPublica

This story was co-published with NPR's Shots blog.

Report: India mulls boosting medtech import tariff

February 27, 2015 by Brad Perriello

India is reportedly considering raising its import tariff on medical devices by 5%.

Report: India mulls boosting medtech import tariff

The government of India is reportedly considering a 5% hike to the basic customs duty on imported medical devices, which make up 80% of its medtech market.

Medical device imports into India are hit with a tariff ranging from 5% to 10%, according to the Economic Times.

Royal Oak claims 'repless' generic sales model saves $100k a year

February 27, 2015 by Brad Perriello

Royal Oak Medical Devices touts its 'repless' generic sales model, saying it can save its hospital customers more than $100,000 a year on their orthopedic implant spends.

Royal Oak claims 'repless' sales model saves $100k a year

Royal Oak Medical Devices says it can save its hospital customers more than $100,000 a year on their orthopedic implant spends, using its so-called 'repless' generic sales model.

St. Jude Medical settles Riata, shareholder suits for $64m

February 27, 2015 by Brad Perriello

St. Jude Medical agrees to settle product liability lawsuits filed over its recalled Riata defibrillator leads and a class-action shareholder's suit accusing it of inflating results for its 2009 3rd quarter.

St. Jude Medical settles Riata, shareholder lawsuits for $64m